Perinatal Toxicology and Psychoactive Substance Use

Alcohol, Tobacco, and Vaping Devices

In utero exposure to legal toxins causes direct structural and vascular alterations in the fetoplacental unit.

There is no safe level of alcohol intake during pregnancy; ethanol and its metabolites freely cross the placenta, causing cellular apoptosis in the neural crest and leading to the spectrum of fetal alcohol spectrum disorders (FASD) and fetal alcohol syndrome (FAS), characterized by microcephaly, facial dysmorphia, and irreversible cognitive impairment.

In the case of smoking and electronic inhalation devices (vaping), nicotine induces sustained vasospasm in the uterine arteries, while carbon monoxide causes persistent cellular hypoxia by displacing oxygen from the hemoglobin molecule.

These alterations lead to intrauterine growth restriction (IUGR), an elevated risk of premature placental abruption in a normally inserted placenta, and a higher incidence of premature rupture of membranes and preterm delivery.

Illicit Substances and Neonatal Withdrawal Syndrome (NWS)

The use of illicit psychoactive substances such as cannabis, cocaine, or opioid derivatives poses critical obstetric and perinatal risks.

Adrenergic stimulants trigger acute vasoconstriction of the placental bed, severe maternal hypertensive spikes, and a marked risk of fetal death in utero.

Meanwhile, regular use of opioids or sedatives induces neurochemical dependence in the fetus.

After the umbilical cord is cut and transplacental supply is abruptly interrupted, the newborn develops neonatal abstinence syndrome (NAS) within the first 24 to 72 hours.

This clinical condition is characterized by autonomic disturbances, marked tremors, hypertonia, inconsolable high-pitched crying, disorganized sucking, and dehydration secondary to diarrhea, requiring prolonged hospitalization and regulated pharmacological support in neonatal intensive care units.